With 'New Rule,' Fed. Circ. Upholds Weight Loss Pill Patent
The Federal Circuit on Thursday invalidated parts of two patents covering Nalpropion Pharmaceuticals Inc.'s weight loss pill Contrave but sided with the company on a third patent, in a decision one...To view the full article, register now.
Already a subscriber? Click here to view full article